Acadia Healthcare Company, Inc. (NASDAQ:ACHC) received a $60.00 target price from equities research analysts at Mizuho in a research note issued on Tuesday. The brokerage presently has a “buy” rating on the stock. Mizuho’s price target points to a potential upside of 35.99% from the company’s current price.

Several other equities research analysts also recently issued reports on the company. Cantor Fitzgerald reiterated a “hold” rating and set a $39.00 price target on shares of Acadia Healthcare in a report on Tuesday. KeyCorp reiterated a “buy” rating and set a $59.00 price target on shares of Acadia Healthcare in a report on Friday, October 20th. BMO Capital Markets assumed coverage on Acadia Healthcare in a report on Monday, October 16th. They set an “outperform” rating and a $52.00 price target for the company. Jefferies Group LLC set a $60.00 price target on Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 11th. Finally, Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Thursday, October 12th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $57.09.

Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 44.12 on Tuesday. The firm has a market cap of $3.88 billion, a P/E ratio of 484.84 and a beta of 1.07. The stock has a 50 day moving average price of $45.55 and a 200 day moving average price of $46.35. Acadia Healthcare has a 12-month low of $32.54 and a 12-month high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Monday, October 30th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. During the same quarter last year, the company posted $0.58 EPS. The company’s quarterly revenue was down 2.4% compared to the same quarter last year. On average, equities analysts expect that Acadia Healthcare will post $2.44 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Mizuho Analysts Give Acadia Healthcare Company, Inc. (ACHC) a $60.00 Price Target” was reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/10/25/mizuho-analysts-give-acadia-healthcare-company-inc-achc-a-60-00-price-target.html.

In other Acadia Healthcare news, Director William Grieco sold 2,000 shares of the company’s stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $51.71, for a total value of $103,420.00. Following the transaction, the director now directly owns 45,013 shares in the company, valued at approximately $2,327,622.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the transaction, the executive vice president now owns 147,286 shares in the company, valued at $7,465,927.34. The disclosure for this sale can be found here. Insiders have sold a total of 3,085,693 shares of company stock worth $157,729,099 in the last three months. 11.10% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. BlackRock Inc. increased its stake in Acadia Healthcare by 27,497.3% in the 1st quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after acquiring an additional 5,127,140 shares during the last quarter. Wellington Management Group LLP increased its stake in Acadia Healthcare by 97.2% in the 1st quarter. Wellington Management Group LLP now owns 6,983,799 shares of the company’s stock worth $384,877,000 after acquiring an additional 3,441,579 shares during the last quarter. Aristotle Capital Management LLC bought a new position in Acadia Healthcare in the 1st quarter worth about $140,071,000. William Blair Investment Management LLC increased its stake in Acadia Healthcare by 1,247.4% in the 2nd quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock worth $105,129,000 after acquiring an additional 1,970,965 shares during the last quarter. Finally, Wells Fargo & Company MN increased its stake in Acadia Healthcare by 30.0% in the 3rd quarter. Wells Fargo & Company MN now owns 6,857,782 shares of the company’s stock worth $339,803,000 after acquiring an additional 1,581,959 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.